Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02462252
Brief Title: Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

First Submitted : May 25, 2015
First Submitted that Met QC Criteria : June 3, 2015
First Posted : June 4, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 16, 2017
Last Update Posted : August 18, 2017